Perfusion CT best predicts outcome after radioembolization of liver metastases: A comparison of radionuclide and CT imaging techniques

European Radiology

Volumn 24, Issue 7, 2014, Pages 1455-1465

  Morsbach, Fabian ^a   Sah, Bert Ram ^a   Spring, Lea ^a   Puippe, Gilbert ^a   Gordic, Sonja ^a   Seifert, Burkhardt ^b   Schaefer, Niklaus ^a   Pfammatter, Thomas ^a   Alkadhi, Hatem ^a   Reiner, Caecilia S ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Computed tomography; Liver metastases; Liver perfusion; Transarterial radioembolisation

Indexed keywords

IOPROMIDE; TECHNETIUM 99M; YTTRIUM 90; MICROSPHERE; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ADULT; AGED; ARTERY PERFUSION; ARTICLE; ARTIFICIAL EMBOLISM; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER PERFUSION; MALE; OUTCOME ASSESSMENT; PERFUSION COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE SPECIFICITY; TRANSARTERIAL RADIOEMBOLIZATION; TREATMENT RESPONSE; VERY ELDERLY; ANGIOGRAPHY; COMPARATIVE STUDY; FOLLOW UP; INTRAARTERIAL DRUG ADMINISTRATION; LIVER NEOPLASMS; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCINTIGRAPHY; SECONDARY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84902358684     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3180-3     Document Type: Article

References (41)

1. Sato KT, Lewandowski RJ, Mulcahy MF et al (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres - safety, efficacy, and survival. Radiology 247:507-515
2. Kennedy AS, McNeillie P, Dezarn WA et al (2009) Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 74:1494-1500
3. Seidensticker R, Denecke T, Kraus P et al (2011) Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases. Cardiovasc Intervent Radiol 35:1066-1073
4. Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969-977
5. Campbell AM, Bailey IH, Burton MA (2000) Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 45:1023-1033 (Pubitemid 30196393)
6. Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C (2004) Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60:1552-1563 (Pubitemid 39601873)
7. Deleporte A, Flamen P, Hendlisz A (2010) State of the art: radiolabeled microspheres treatment for liver malignancies. Expert Opin Pharmacother 11:579-586
8. Cosimelli M, Mancini R, Carpanese L et al (2012) Integration of radioembolisation into multimodal treatment of liver-dominant metastatic colorectal cancer. Expert Opin Ther Targets 16:S11-S16
9. Herba MJ, Thirlwell MP (2002) Radioembolization for hepatic metastases. Semin Oncol 29:152-159 (Pubitemid 34297286)
10. Sato KT, Omary RA, Takehana C et al (2009) The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases. J Vasc Interv Radiol 20:1564-1569
11. Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412-425
12. Dhabuwala A, Lamerton P, Stubbs RS (2005) Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following selective internal radiation therapy (SIRT). BMC Nucl Med 5:7
13. Morsbach F, Pfammatter T, Reiner CS et al (2013) Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Invest Radiol 48:787-794
14. Brix G, Lechel U, Petersheim M, Krissak R, Fink C (2011) Dynamic contrast-enhanced CT studies: balancing patient exposure and image noise. Invest Radiol 46:64-70
15. Goetti R, Leschka S, Desbiolles L et al (2010) Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases. Invest Radiol 45:419-426
16. Huda W, Ogden KM, Khorasani MR (2008) Converting dose-length product to effective dose at CT. Radiology 248:995-1003
17. Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13-23 (Pubitemid 46589861)
18. Lau WY, Kennedy AS, Kim YH et al (2012) Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys 82:401-407
19. Seidensticker R, Seidensticker M, Damm R et al (2012) Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol 35:1109-1118
20. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
21. Islam R, Chyou PH, Burmester JK (2013) Modeling efficacy of bevacizumab treatment for metastatic colon cancer. J Cancer 4:330-335
22. Nace GW, Steel JL, Amesur N et al (2011) Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol 2011:571261
23. Marin D, Nelson RC, Samei E et al (2009) Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection-initial clinical experience. Radiology 251:771-779
24. Saddi KA, Chefd'hotel C, Cheriet F (2007) Large deformation registration of contrast-enhanced images with volume-preserving constraint. Proc Spie, 6512
25. Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405-411 (Pubitemid 23216260)
26. Blomley MJ, Coulden R, Dawson P et al (1995) Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19:424-433
27. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K (2004) Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 11:215-223 (Pubitemid 38140292)
28. Flamen P, Vanderlinden B, Delatte P et al (2008) Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin microspheres. Phys Med Biol 53:6591-6603
29. Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420-428
30. Ulrich G, Dudeck O, Furth C et al (2013) Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres. J Nucl Med 54:516-522
31. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS (2005) Perfusion imaging of the liver: current challenges and future goals. Radiology 234:661-673 (Pubitemid 40250807)
32. Tochetto SM, Rezai P, Rezvani M et al (2010) Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDGPET? Radiology 255:164-172
33. Lien WM, Ackerman NB (1970) The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 68:334-340
34. Ho S, Lau WY, Leung TW et al (1997) Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 70:823-828 (Pubitemid 27373117)
35. Garin E, Lenoir L, Rolland Y et al (2012) Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 53:255-263
36. Forner A, Ayuso C, Varela M et al (2009) Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115:616-623
37. Spira D, Neumeister H, Spira SM et al (2013) Assessment of tumor vascularity in lung cancer using volume perfusion CT (VPCT) with histopathologic comparison: a further step toward an individualized tumor characterization. J Comput Assist Tomogr 37:15-21
38. Yang L, Zhang XM, Zhou XP et al (2010) Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization. J Vasc Interv Radiol 21:1841-1846
39. Tacelli N, Santangelo T, Scherpereel A et al (2013) Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy. Eur Radiol 23:2127-2136
40. Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A (2007) CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 244:486-493 (Pubitemid 47080881)
41. Goh V, Halligan S, Daley F, Wellsted DM, Guenther T, Bartram CI (2008) Colorectal tumor vascularity: quantitative assessment with multidetector CT - do tumor perfusion measurements reflect angiogenesis? Radiology 249:510-517